Previously, in addition to the close relationship between RPL10 R98S mutation and leukemia [26–28], the expression of PRL10 has been indicated to affect the development of various cancers, including prostate cancer, ovarian cancer and pancreatic cancer [21–25, 29]. Here, RPL10 is linked to prostate carcinoma.